Atlas Trials

Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer

Clinical trial NCT03037437 · COMPLETED

Trial details

NCT number
NCT03037437
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Cancer
Start date
2017-02-16
Primary completion
2025-06-27
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.